Index RUT P/E - EPS (ttm) -0.09 Insider Own 24.81% Shs Outstand 390.25M Perf Week 14.60%
Market Cap 1.61B Forward P/E - EPS next Y -0.05 Insider Trans 0.17% Shs Float 385.35M Perf Month 22.18%
Enterprise Value - PEG - EPS next Q -0.03 Inst Own 28.67% Short Float 12.54% Perf Quarter 8.84%
Income -43.10M P/S 1.00 EPS this Y -26.20% Inst Trans 37.65% Short Ratio 5.30 Perf Half Y -14.21%
Sales 1.61B P/B 4.40 EPS next Y 54.35% ROA -6.74% Short Interest 48.33M Perf YTD -0.32%
Book/sh 0.71 P/C - EPS next 5Y - ROE -12.59% 52W High 4.87 -35.52% Perf Year 18.49%
Cash/sh - P/FCF - EPS past 3/5Y 60.49% -237.67% ROIC -12.52% 52W Low 2.12 48.11% Perf 3Y 24.11%
Dividend Est. - EV/EBITDA - Sales past 3/5Y -3.77% -Gross Margin - Volatility 5.56% 4.40% Perf 5Y -71.71%
Dividend TTM - EV/Sales - EPS Y/Y TTM 66.16% Oper. Margin -2.65% ATR (14) 0.14 Perf 10Y -
Dividend Ex-Date - Quick Ratio - Sales Y/Y TTM -4.87% Profit Margin -2.68% RSI (14) 66.09 Recom 2.00
Dividend Gr. 3/5Y - - Current Ratio 1.80 EPS Q/Q -236.84% SMA20 14.09% Beta 2.10 Target Price 3.65
Payout - Debt/Eq 0.00 Sales Q/Q 34.07% SMA50 11.68% Rel Volume 0.64 Prev Close 3.06
Employees 570 LT Debt/Eq 0.00 Earnings Aug 05 AMC SMA200 -6.97% Avg Volume 9.12M Price 3.14
IPO Jun 12, 2020 Option/Short Yes / Yes EPS/Sales Surpr. -117.39% 1.99% Trades
Volume 5,858,947 Change 2.61%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-17-24 Initiated Craig Hallum
Buy
$6
Oct-07-24 Initiated UBS
Neutral
$4
Feb-02-22 Upgrade Cowen
Underperform → Market Perform
$7 → $3
Feb-02-22 Initiated Canaccord Genuity
Buy
$6
Jan-19-22 Initiated SVB Leerink
Mkt Perform
$3
Jan-10-22 Resumed Citigroup
Neutral
$9 → $3.50
Jan-07-22 Downgrade Credit Suisse
Neutral → Underperform
$9 → $3.50
Sep-10-21 Initiated Cowen
Underperform
$7
Sep-02-21 Resumed Citigroup
Neutral
$10
Jul-12-21 Downgrade JP Morgan
Neutral → Underweight
$9
Jun-10-21 Downgrade BofA Securities
Neutral → Underperform
$10
May-17-21 Downgrade BofA Securities
Buy → Neutral
$15 → $9
Mar-09-21 Initiated Credit Suisse
Neutral
$10
Feb-02-21 Initiated Citigroup
Buy
$19
Feb-01-21 Initiated JP Morgan
Neutral
$15
Show Previous Ratings
Sep-15-25 08:17AM
Sep-09-25 11:30AM
08:30AM
Sep-03-25 02:20PM
Aug-29-25 09:47AM
11:37PM
Loading…
Aug-27-25 11:37PM
Aug-21-25 09:55AM
Aug-17-25 11:41PM
06:36PM
Aug-13-25 05:50PM
12:21AM
Aug-12-25 11:55PM
11:09AM
Aug-06-25 01:11PM
10:39AM
03:35AM
Loading…
03:35AM
Aug-05-25 06:05PM
05:55PM
04:05PM
Aug-04-25 04:30PM
09:40AM
Aug-03-25 11:19PM
Aug-01-25 08:49AM
Jul-31-25 08:30AM
12:37AM
Jul-29-25 04:30PM
Jul-23-25 11:25AM
09:42AM
Jul-22-25 09:15AM
Jul-21-25 04:05PM
01:16PM
Loading…
01:16PM
Jul-17-25 08:30AM
Jul-11-25 03:30PM
11:27AM
Jul-09-25 08:30AM
01:19AM
Jul-08-25 08:30AM
Jul-07-25 09:11AM
Jul-03-25 11:35PM
Jul-02-25 11:34AM
Jun-30-25 02:29PM
08:30AM
Jun-27-25 05:23AM
Jun-23-25 12:34PM
Jun-20-25 11:53AM
Jun-03-25 11:44AM
Jun-02-25 12:22PM
May-28-25 09:40AM
May-27-25 11:17AM
May-19-25 10:08AM
May-15-25 09:40AM
May-12-25 12:00PM
May-07-25 12:28PM
May-06-25 05:55PM
04:05PM
09:45AM
May-05-25 11:09AM
09:46AM
09:16AM
May-02-25 12:40AM
May-01-25 04:30PM
Apr-29-25 11:29AM
09:00AM
Apr-22-25 06:47PM
05:00PM
Apr-21-25 04:05PM
Apr-08-25 04:05PM
06:46AM
Apr-07-25 04:05PM
Mar-19-25 04:51PM
05:09AM
Mar-18-25 05:03AM
Mar-03-25 09:00AM
Feb-27-25 04:58PM
04:05PM
Feb-26-25 07:33AM
Feb-24-25 04:05PM
Feb-18-25 04:05PM
Feb-05-25 09:00AM
Feb-03-25 12:01AM
Jan-24-25 06:50AM
Jan-14-25 09:30AM
Jan-13-25 09:00AM
Jan-07-25 12:27PM
09:00AM
Dec-17-24 04:05PM
Nov-20-24 08:45AM
Nov-12-24 09:00AM
Nov-07-24 04:01PM
(GuruFocus.com) -15.63%
-7.08%
Nov-06-24 04:05PM
Nov-05-24 07:45AM
Oct-29-24 04:05PM
Oct-23-24 04:05PM
Oct-17-24 09:18PM
Oct-15-24 09:15AM
Oct-10-24 05:03PM
Oct-08-24 06:15AM
Sep-26-24 04:00PM
Sep-03-24 11:54PM
04:05PM
Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. The company was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Wilmington, DE.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Loengard Anna U Director Aug 13 '25 Buy 2.59 26,500 68,755 29,610 Aug 14 04:44 PM Garipalli Vivek Director Aug 07 '25 Buy 2.24 415,000 929,600 1,824,267 Aug 08 04:07 PM Garipalli Vivek Director Aug 08 '25 Buy 2.17 31,980 69,397 1,856,247 Aug 08 04:07 PM Reynoso Jamie L. CEO, Medicare Advantage Aug 04 '25 Sale 2.89 6,823 19,718 3,261,485 Aug 06 04:59 PM JAMIE REYNOSO Officer Aug 04 '25 Proposed Sale 2.78 6,823 18,968 Aug 04 04:22 PM Wai Conrad CEO, Counterpart Health Jul 22 '25 Sale 3.29 118,600 390,194 1,494,898 Jul 24 04:11 PM Wai Conrad CEO, Counterpart Health Jul 23 '25 Sale 3.32 91,197 302,774 1,403,701 Jul 24 04:11 PM Reynoso Jamie L. CEO, Medicare Advantage Jul 03 '25 Sale 2.58 19,789 51,056 3,308,539 Jul 08 05:15 PM Reynoso Jamie L. CEO, Medicare Advantage Jul 07 '25 Sale 2.85 2,012 5,734 3,297,821 Jul 08 05:15 PM Wai Conrad Officer Jul 08 '25 Proposed Sale 3.25 225,000 731,250 Jul 08 04:04 PM JAMIE REYNOSO Officer Jul 07 '25 Proposed Sale 2.56 2,012 5,151 Jul 07 04:28 PM JAMIE REYNOSO Officer Jul 03 '25 Proposed Sale 2.59 19,789 51,254 Jul 03 01:27 PM Reynoso Jamie L. CEO, Medicare Advantage Jun 17 '25 Sale 2.86 20,450 58,487 3,196,401 Jun 18 05:26 PM JAMIE REYNOSO Officer Jun 17 '25 Proposed Sale 2.92 20,450 59,714 Jun 17 04:21 PM Edwards Carladenise Armbrister Director Mar 07 '25 Sale 3.61 200,000 722,000 273,227 Mar 11 04:12 PM Priest Brady Patrick CEO of Home Care Mar 06 '25 Sale 3.68 75,000 276,000 2,418,151 Mar 07 06:11 PM Soares Karen General Counsel & Secretary Mar 06 '25 Sale 3.80 52,500 199,500 1,299,663 Mar 07 05:59 PM Edwards Carladenise Armbrister Director Mar 07 '25 Proposed Sale 3.72 200,000 744,000 Mar 07 05:05 PM Priest Brady Patrick Officer Mar 06 '25 Proposed Sale 3.68 75,000 276,269 Mar 06 06:32 PM Soares Karen Officer Mar 05 '25 Proposed Sale 3.80 52,500 199,500 Mar 06 05:10 PM Soares Karen Officer Mar 06 '25 Proposed Sale 3.68 75,000 276,269 Mar 06 05:05 PM Garipalli Vivek Director Jan 07 '25 Option Exercise 0.00 1,670,965 0 3,080,232 Jan 10 04:34 PM
